Palvella Therapeutics (PVLA) FCF Margin (QoQ) (2014 - 2024)
Powered by 
Analysis
Palvella Therapeutics (PVLA) FCF Margin (QoQ) (2014 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Palvella Therapeutics | 2.24 Bn | 1.93 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -365,430.00 |
| Dec 31, 2023 | 162,522.00 |
| Sep 30, 2023 | 1,704.00 |
| Jun 30, 2023 | 48,225.00 |
| Mar 31, 2023 | -32,841.00 |
| Dec 31, 2022 | -5,694.00 |
| Sep 30, 2022 | 27,417.00 |
| Jun 30, 2022 | -23,225.00 |
| Mar 31, 2022 | -7,234.00 |
| Dec 31, 2021 | 23,197.00 |
| Sep 30, 2021 | -126,905.00 |
| Jun 30, 2021 | 99,699.00 |
| Mar 31, 2021 | 65,202.00 |
| Dec 31, 2020 | -51,662.00 |
| Sep 30, 2020 | -13,261.00 |
| Jun 30, 2020 | 3,225.00 |
| Mar 31, 2020 | -4,091.00 |
| Dec 31, 2019 | -258.00 |
| Sep 30, 2019 | 13,365.00 |
| Jun 30, 2019 | -4,057.00 |